Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: Focus on dosing regimen, dosage form, and formulation

被引:18
作者
Chen, ML [1 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Off Pharmaceut Sci, Rockville, MD 20857 USA
关键词
D O I
10.1016/j.clpt.2005.06.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:322 / 329
页数:8
相关论文
共 77 条
[1]   ROUTE OF ADMINISTRATION AND SEX-DIFFERENCES IN THE PHARMACOKINETICS OF ASPIRIN, ADMINISTERED AS ITS LYSINE SALT [J].
AARONS, L ;
HOPKINS, K ;
ROWLAND, M ;
BROSSEL, S ;
THIERCELIN, JF .
PHARMACEUTICAL RESEARCH, 1989, 6 (08) :660-666
[2]  
[Anonymous], 2005, PHYS DESK REFERENCE, V59th
[3]  
BARHEIYA RH, 1996, J CLIN PSYCHOPHARM, V16, P19
[4]  
Beierle I, 1999, INT J CLIN PHARM TH, V37, P529
[5]  
Bies Robert R, 2003, J Gend Specif Med, V6, P12
[6]   Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients [J].
Bleck, JS ;
Thiesemann, C ;
Kliem, V ;
Christians, U ;
Hecker, H ;
Repp, H ;
Frei, U ;
WesthoffBleck, M ;
Manns, M ;
Sewing, KF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (06) :551-556
[7]  
Blychert E, 1992, Blood Press Suppl, V2, P1
[8]   GENDER-RELATED DIFFERENCES IN XENOBIOTIC METABOLISM [J].
BONATE, PL .
JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (08) :684-690
[9]  
Bussemer T, 2001, CRIT REV THER DRUG, V18, P433
[10]   Pharmacokinetic analysis of bioequivalence trials: Implications for sex-related issues in clinical pharmacology and biopharmaceutics [J].
Chen, ML ;
Lee, SC ;
Ng, MJ ;
Schuirmann, DJ ;
Lesko, LJ ;
Williams, RL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (05) :510-521